Bioda Diagnostics (Wuhan) Co., Ltd. (hereinafter referred to as Bioda) has access to EU CE market for its test kits against COVID-19 on March 30, 2020, fighting for global epidemic resistance!

Novel Coronavirus (COVID-19) Antibody IgM/IgG Test (Colloidal Gold)

The Novel Coronavirus (COVID-19) Antibody IgM/IgG Test developed by Bioda uses colloidal gold immunochromatography technology and capture method to detect (COVID-19) IgM/IgG antibody in human body, which is used for the qualitative test of (COVID-19) IgM/IgG antibodies in human serum, plasma and venous whole blood samples in vitro. The test results will be observed with the naked eye after about 15 minutes. It can be used as a supplementary test indicator for suspected cases whose COVID-19 nucleic acid tests show negative or used in conjunction with nucleic acid tests in the diagnosis of suspected cases. The company has obtained the EU market access for this product which can be sold in many countries and regions around the world. Bioda will be dedicated to providing its own strength for global anti-epidemic!